160 related articles for article (PubMed ID: 18852226)
1. Changes in body composition after glucocorticoid therapy in patients with systemic lupus erythematosus.
Mok CC; To CH; Ma KM
Lupus; 2008 Nov; 17(11):1018-22. PubMed ID: 18852226
[TBL] [Abstract][Full Text] [Related]
2. Four years follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus.
Uaratanawong S; Deesomchok U; Hiransuttikul N; Uaratanawong S
J Med Assoc Thai; 2004 Nov; 87(11):1374-9. PubMed ID: 15825716
[TBL] [Abstract][Full Text] [Related]
3. Factors that determine body composition of female systemic lupus erythematosus (SLE) patients in Sri Lanka: a comparative study using dual-energy x-ray absorptiometry.
Liyanage A; Lekamwasam S; Dissanayake SP; Munidasa D
Lupus; 2013 Aug; 22(9):972-6. PubMed ID: 23861026
[TBL] [Abstract][Full Text] [Related]
4. Body composition after endogenous (Cushing's syndrome) and exogenous (rheumatoid arthritis) exposure to glucocorticoids.
Resmini E; Farkas C; Murillo B; Barahona MJ; Santos A; Martínez-Momblán MA; Roig O; Ybarra J; Geli C; Webb SM
Horm Metab Res; 2010 Jul; 42(8):613-8. PubMed ID: 20514604
[TBL] [Abstract][Full Text] [Related]
5. Body composition, lipid and lipoprotein levels in childhood-onset systemic lupus erythematosus.
Lilleby V; Haugen M; Mørkrid L; Frey Frøslie K; Holven KB; Førre O
Scand J Rheumatol; 2007; 36(1):40-7. PubMed ID: 17454934
[TBL] [Abstract][Full Text] [Related]
6. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment.
Briot K; Gossec L; Kolta S; Dougados M; Roux C
J Rheumatol; 2008 May; 35(5):855-61. PubMed ID: 18381782
[TBL] [Abstract][Full Text] [Related]
7. Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls.
Delpierre C; Bonnet E; Marion-Latard F; Aquilina C; Obadia M; Marchou B; Massip P; Perret B; Bernard J
J Clin Densitom; 2007; 10(4):376-80. PubMed ID: 17888698
[TBL] [Abstract][Full Text] [Related]
8. Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatment.
Briot K; Garnero P; Le Henanff A; Dougados M; Roux C
Ann Rheum Dis; 2005 Aug; 64(8):1137-40. PubMed ID: 15642695
[TBL] [Abstract][Full Text] [Related]
9. Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids.
Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah S; Chow SK; Goh EM
Lupus; 2009 Feb; 18(2):178-81. PubMed ID: 19151123
[TBL] [Abstract][Full Text] [Related]
10. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
11. Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapy.
Mease PJ; Ginzler EM; Gluck OS; Schiff M; Goldman A; Greenwald M; Cohen S; Egan R; Quarles BJ; Schwartz KE
J Rheumatol; 2005 Apr; 32(4):616-21. PubMed ID: 15801015
[TBL] [Abstract][Full Text] [Related]
12. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.
Galvão DA; Spry NA; Taaffe DR; Newton RU; Stanley J; Shannon T; Rowling C; Prince R
BJU Int; 2008 Jul; 102(1):44-7. PubMed ID: 18336606
[TBL] [Abstract][Full Text] [Related]
13. Fat conversion of femoral marrow in glucocorticoid-treated patients: a cross-sectional and longitudinal study with magnetic resonance imaging.
Vande Berg BC; Malghem J; Lecouvet FE; Devogelaer JP; Maldague B; Houssiau FA
Arthritis Rheum; 1999 Jul; 42(7):1405-11. PubMed ID: 10403268
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use.
Santiago RA; Silva CA; Caparbo VF; Sallum AM; Pereira RM
Scand J Rheumatol; 2008; 37(1):40-7. PubMed ID: 18189194
[TBL] [Abstract][Full Text] [Related]
15. Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.
Sánchez-Guerrero J; Fragoso-Loyo HE; Neuwelt CM; Wallace DJ; Ginzler EM; Sherrer YR; McIlwain HH; Freeman PG; Aranow C; Petri MA; Deodhar AA; Blanton E; Manzi S; Kavanaugh A; Lisse JR; Ramsey-Goldman R; McKay JD; Kivitz AJ; Mease PJ; Winkler AE; Kahl LE; Lee AH; Furie RA; Strand CV; Lou L; Ahmed M; Quarles B; Schwartz KE
J Rheumatol; 2008 Aug; 35(8):1567-75. PubMed ID: 18634158
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of body composition and bone mineral density in healthy men from Argentina.
Seijo M; Deferrari JM; Bagur A; Fernández MC; Mastaglia SR; Parisi MS; Oliveri B
J Clin Densitom; 2007; 10(4):381-5. PubMed ID: 17662629
[TBL] [Abstract][Full Text] [Related]
17. Three year follow-up of body composition changes in pre-menopausal women with systemic lupus erythematosus.
Kipen Y; Briganti EM; Strauss BJ; Littlejohn GO; Morand EF
Rheumatology (Oxford); 1999 Jan; 38(1):59-65. PubMed ID: 10334684
[TBL] [Abstract][Full Text] [Related]
18. The effect of long-term glucocorticoids on bone metabolism in systemic lupus erythematosus patients: the prevalence of its anti-inflammatory action upon bone resorption.
Korczowska I; Olewicz-Gawlik A; Hrycaj P; Lacki J
Yale J Biol Med; 2003; 76(2):45-54. PubMed ID: 15369631
[TBL] [Abstract][Full Text] [Related]
19. Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma.
Lee H; McGovern K; Finkelstein JS; Smith MR
Cancer; 2005 Oct; 104(8):1633-7. PubMed ID: 16116596
[TBL] [Abstract][Full Text] [Related]
20. Relationship between body composition and bone mineral density (BMD) in perimenopausal Korean women.
Kim CJ; Oh KW; Rhee EJ; Kim KH; Jo SK; Jung CH; Won JC; Park CY; Lee WY; Park SW; Kim SW
Clin Endocrinol (Oxf); 2009 Jul; 71(1):18-26. PubMed ID: 19178508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
